For those who suffered from more than two episodes of CVT or had a severe hereditary thrombophilia (e.g., homozygous FVL and prothrombin G20210A mutation, PC, PS, antithrombin deficiency, complex thrombophilia, APS), long-term anticoagulant therapy should be considered [27]. Here, PRB2 is linked to hereditary antithrombin deficiency.